Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Daridorexant: First Approval
Anthony Markham
Drugs (2022) Vol. 82, Iss. 5, pp. 601-607
Open Access | Times Cited: 57
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Dieter Kunz, Yves Dauvilliers, Heike Beneš, et al.
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 93-106
Open Access | Times Cited: 53
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 42
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 24
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 49
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 17
Effects of hypnotics on obstructive sleep apnea endotypes and severity: Novel insights into pathophysiology and treatment
Sophie G. Carter, Danny J. Eckert
Sleep Medicine Reviews (2021) Vol. 58, pp. 101492-101492
Closed Access | Times Cited: 40
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Shahrokh Javaheri, Sogol Javaheri, David Gozal, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1224-1240
Closed Access | Times Cited: 6
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem
Mike Ufer, Debra Kelsh, Kerri A. Schoedel, et al.
SLEEP (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 31
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Obstructive sleep apnea syndrome, orexin, and sleep–wake cycle: The link with the neurodegeneration
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Daridorexant for the Treatment of Insomnia
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15
Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease
Marie‐Laure Boof, Jasper Dingemanse, Mareile Brunke, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 19
Assessment of the effect of the dual orexin receptor antagonist daridorexant on various indices of disease severity in patients with mild to moderate obstructive sleep apnea
Marie‐Laure Boof, Mike Ufer, Ingo Fietze, et al.
Sleep Medicine (2022) Vol. 92, pp. 4-11
Open Access | Times Cited: 13
Functional roles of orexin in obstructive sleep apnea: From clinical observation to mechanistic insights
Suchanya Sithirungson, Nuntigar Sonsuwan, Siriporn C. Chattipakorn, et al.
Sleep Medicine (2022) Vol. 101, pp. 40-49
Closed Access | Times Cited: 13
Daridorexant in Insomnia Disorder: A Profile of Its Use
Tina Nie, Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 267-274
Open Access | Times Cited: 8
Daridorexant for the treatment of insomnia disorder: findings and implications
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
Pharmacological interventions for the treatment of obstructive sleep apnea syndrome
Jin Liu, Xiaolan Yang, Guangcai Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 2
Clinical safety of daridorexant in insomnia treatment: Analysis of FDA adverse event reports
Qi Wang, Qin Zhou, Zhiqiang Du, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 552-559
Closed Access | Times Cited: 2
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Dwaipayan Sarathi Chakraborty, Shouvik Choudhury, Sandeep Lahiry
Sleep Science (2023) Vol. 16, Iss. 02, pp. 256-264
Open Access | Times Cited: 6
Daridorexant: Comprehensive Review of A New Oral Agent for the Treatment of Insomnia
Juliane Park, Kandon P. Render, Drew W. Cates
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 5
Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia
Erin St. Onge, Bradley Phillips, Casey Rowe
Journal of Pharmacy Technology (2022) Vol. 38, Iss. 5, pp. 297-303
Open Access | Times Cited: 8
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in the Treatment of Insomnia
Dwaipayan Sarathi Chakraborty, Shouvik Choudhury, Sandeep Lahiry
Current Drug Research Reviews (2022) Vol. 15, Iss. 2, pp. 149-158
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top